What's new

On 5 October 2018, following a direction from ARPANSA’s CEO Dr Carl-Magnus Larsson, the Australian Nuclear Science and Technology Organisation (ANSTO) provided ARPANSA with a report produced by an

On 19 September 2018, at the International Atomic Energy Agency (IAEA) General Conference in Vienna, ARPANSA’s Deputy Chief Executive Officer, Gillian Hirth, alongside the Deputy Chairman of the Board of the Dutch Authority for Nuclear Safety and Radiation Protection (ANVS), Marco Brugmans, signed a memorandum of understanding (MoU).

On 29 June 2018, the CEO of ARPANSA, Dr Carl-Magnus Larsson, issued the Australian Nuclear Science and Technology Organisation with a direction under section 41(1A) of the Australian Radiation Protection and Nuclear Safety Act 1998.

The International Commission on Non-Ionizing Radiation Protection has published draft guidelines for public consultation. ARPANSA is revising its Radiofrequency Standard and will consider the ICNIRP guidelines in this process.

An article published in the Daily Mail Australia on 18 June 2018, reports that using a mobile phone can be as damaging on your skin as being out in the sun. It is concerning that the exposure from smartphones has been compared to the same time spent in the sun.

On 24-25 May 2018, ARPANSA and the International Atomic Energy Agency hosted an Asia-Pacific region workshop on the Establishment and Maintenance of a National Dose Registry for those who work with radiation as part of their jobs.

ARPANSA’s CEO, Dr Carl-Magnus Larsson has issued a licence to the Australian Nuclear Science and Technology Organisation (ANSTO) to operate the ANSTO Nuclear Medicine Molybdenum-99 (Mo-99) Facility (the ANM Facility).

A series of animal studies on mobile phone radiofrequency radiation and health have been conducted over two years by the United States Department of Health and Human Services National Toxicology Program.